Dopaminergic medication effects on the speech of individuals with Parkinson's disease

Journal of Medical Speech-Language Pathology

Volumn 17, Issue 3, 2009, Pages 125-144

  Spencer, Kristie A ^a   Morgan, Kelly W ^a   Blond, Emily ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; CARBIDOPA; CARBIDOPA PLUS LEVODOPA; CLONAZEPAM; ENTACAPONE; LEVODOPA; PRAMIPEXOLE; RASAGILINE; ROPINIROLE; SELEGILINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DRUG EFFECT; FEMALE; HUMAN; IDIOPATHIC PARKINSON DISEASE; MALE; PARKINSON DISEASE; PHONATION; PRIORITY JOURNAL; READING; SPEECH INTELLIGIBILITY; SPEECH LANGUAGE PATHOLOGIST; SPEECH RATE; VISUAL ANALOG SCALE; VOICE;

EID: 78650495821     PISSN: 10651438     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Agid, Y. (1997). Levodopa: Is toxicity a myth? Neurology, 50(4), 858-863.
2. Beck, A. T., Steer, R. G., & Brown, G. K. (1996). Beck Depression Inventory-II. San Antonio, TX: The Psychological Corporation.
3. Benton, A., de Hamsher, K., Varney, N., & Spreen, O. (1983). Contributions to neuropsychological assessment - A clinical manual. New York: Oxford University Press.
4. Cahill, L. M., Murdoch, B. E, Theodoros, D. G., Triggs, E. J., Charles, B. G., & Yao, A. A. (1998). Effect of oral levodopa treatment on articulatory function in Parkinson's disease: Preliminary results. Motor Control, 2, 161-172.
5. Chan, K. M. K., & Yiu, E. M.-L. (2002). The effect of anchors and training on the reliability of perceptual voice evaluation. Journal of Speech, Language and Hearing Research, 45, 111-126. (Pubitemid 34131113)
6. Cools, R. (2006). Dopaminergic modulation of cognitive function-implications for L-dopa treatment in Parkinson's disease. Neuroscience and Biobehavioral Reviews, 30, 1-23.
7. Defer, G. L., Widner, H., Marie, R. M., Remy, P., & Levivier, M. (1999). Core assessment program for surgical intervention therapies in Parkinson's disease (CAPSIT-PD). Movement Disorders, 14, 572-584. (Pubitemid 30011449)
8. De Letter, M., Santens, P., De Bodt, M., Boon, P., & Van Borsel, J. (2006). Levodopa-induced alterations in speech rate in advanced Parkinson's disease. Acta Neurologica Belgium, 106, 19-22. (Pubitemid 43805090)
9. De Letter, M., Santens, P., De Bodt, M., Van Maele, G., Van Borsel, J., & Boon, P. (2007). The effect of levodopa on respiration and word intelligibility in people with advanced Parkinson's disease. Clinical Neurology and Neurosurgery, 109, 495-500.
10. De Letter, M., Santens, P., Estercam, I., Van Maele, G., De Bodt, M., Boon, P., & Van Borsel, J. (2007). Levodopa-induced modifications of prosody and comprehensibility in advanced Parkinson's disease as perceived by professional listeners. Clinical Linguistics & Phonetics, 21(10), 783-791. (Pubitemid 47470819)
11. De Letter, M., Santens, P., & Van Borsel, J. (2005). The effects of levodopa on intelligibility in Parkinson's disease. Journal of Communication Disorders, 38, 187-196. (Pubitemid 40312802)
12. Della Sala, S., Gray, C., Baddeley, A., & Wilson, L. (1997). The visual patterns test: A new test of short term visual recall. Feltham, Suffolk: Thames Valley Test Company.
13. Eadie, T. L., & Baylor, C. R. (2006). The effect of perceptual training on inexperienced listeners' judgements of dysphonic voice. Journal of Voice, 20, 527-545.
14. Eadie, T. L., VanBoven, L., Stubbs, K., & Giannini, E. (in press). The effect of musical background on judgments of dysphonia. Journal of Voice.
15. Fairbanks, G. (1960). Voice and articulation drillbook. New York: Harper & Brothers.
16. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
17. Frank, M., Seeberger, L., & O'Reilly, R. (2004). By carrot or by stick: Cognitive reinforcement learning in parkinsonism. Science, 306, 1940-1943.
18. Gallena, S., Smith, P. J., Zeffiro, T., & Ludlow, C. L. (2001). Effects of levodopa on laryngeal muscle activity for voice onset and offset in Parkinson disease. Journal of Speech, Language, and Hearing Research, 44, 1284-1299. (Pubitemid 34008277)
19. Gerratt B. R., Kreiman, J., Antonanazas-Barroso, N., & Berke, G. S. (1993). Comparing internal and external standards in voice quality judgements. Journal of Speech and Hearing Research, 36, 14-20. (Pubitemid 23084253)
20. Goberman, A., & Blomgren, M. (2003). Parkinsonian speech disfluencies: Effects of L-dopa-related fluctuations. Journal of Fluency Disorders, 28, 55-70. (Pubitemid 36438619)
21. Goberman, A., Coelho, C., & Robb, M. (2002). Phonatory characteristics of parkinsonian speech before and after morning medication: The ON and OFF status. Journal of Communication Disorders, 35, 217-239. (Pubitemid 34665409)
22. Goberman, A., Coelho, C., & Robb, M. (2005). Prosodic characteristics of Parkinsonian speech: The effect of levodopa-based medication. Journal of Medical Speech-Language Pathology, 13(1), 51-68. (Pubitemid 40471920)
23. Goetz, C. G., Stebbins, G. T., & Blasucci, L. M. (2000). Differential progression of motor impairment in levodopa-treated Parkinson's disease. Movement Disorders, 15(3), 479-484. (Pubitemid 30333219)
24. Goldman-Eisler, F. (1968). Psycholinguistics: Experiments in spontaneous speech. New York: Academic Press.
25. Goodglass, H., & Kaplan, E. (1983). Assessment of aphasia and related disorders (2nd ed.). Philadelphia: Lea & Febiger.
26. Gotham, A. M., Brown, R. G., & Marsden, C. D. (1986). Levodopa treatment may benefit or impair "frontal" function in Parkinson's disease. The Lancet, 2, 970-971.
27. Gotham, A., Brown, R. G., & Marsden, C. D. (1988). "Frontal" cognitive function in patients with Parkinson's disease "on" and "off" levodopa. Brain, 111, 299-321.
28. Heaton, R. K., Chelune, G. J., Talley, J. L., Kay, G. G., & Curtiss, G. (1993). Wisconsin Card Sorting Test. Odessa, FL: Psychological Assessment Resources, Inc.
29. Ho, A., Bradshaw, J. L., & Iansek, R. (2008). For better or worse: The effect of Levodopa on speech in Parkinson's disease. Movement Disorders, 23(4), 574-580.
30. Hoehn, M. M., & Yahr, M. D. (1967). Parkinsonism: Onset, progression and mortality. Neurology, 17, 427-442.
31. Kay, J., Lesser, R., & Coltheart, M. (1992). Psycholinguistic assessment of language processing in aphasia. Hove, UK: Lawrence Erlbaum.
32. Kompoliti, K., Wang, Q. E., Goetz, C. G., Leurgans, S., & Raman, R. (1999). Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease. Neurology, 54(2), 458-462.
33. Kreiman, J., Gerratt, B. R., Precoda, K., & Berke, G. (1992). Individual differences in voice quality perception. Journal of Speech and Hearing Research, 35, 512-520.
34. Leder, S. (1996). Adult onset of stuttering as a presenting sign in a Parkinson-like syndrome: A case report. Journal of Communication Disorders, 29, 471-478.
35. Louis, E. D., Winfield, L., Fahn, S., & Ford, B. (2001). Speech dysfluency exacerbated by levodopa in Parkin- son's disease. Movement Disorders, 16(3), 562-581. (Pubitemid 36041169)
36. McLellan, D. L. (1972). Levodopa in parkinsonism: Reduction in the electromyographic silent period in its relationship with tremor. Journal of Neurology, Neurosurgery, and Psychiatry, 35, 373-378.
37. McHenry, M. (2001). The effect of a dopamine agonist on dysarthric speech production: A case study. Journal of Communication Disorders, 34, 397-414.
38. Mehta, M., Owen, A. M., Sahakian, B. J., Mavaddat, N., Pickard, J. D., & Robbins, T. W. (2000). Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. Neuroscience, 20, 1-6.
39. Miller, N., Allcock, L., Jones, D., Noble, E., Hildreth, A., & Burn, D. (2007). Prevalence and pattern of perceived intelligibility changes in Parkinson's disease. Journal of Neurological Neurosurgery, Psychiatry Online, 1-12.
40. Nakano, K. K., Zubick, H., & Tyler, R. (1973). Speech defects of parkinsonian patients: Effects of levodopa therapy on speech intelligibility. Neurology, 23, 865-870.
41. Nunnally, J. C., & Berstein, I. (1994). Psychometric theory. New York: McGraw Hill.
42. Ruff, R. M., Light, R. H., Parker, S. B., & Levin, H. S. (1996) Benton controlled oral word association test: Reliability and updated norms. Archives of Clinical Neuropsychology, 11(4), 329-338.
43. Sanabria, J., Ruiz, P. G., Gutierrez, R., Marquez, F., Escobar, P., Gentil, M., & Cenjor, C. (2001). The effect of Levodopa on vocal function in Parkinson's disease. Clinical Neuropharmacology, 24(2), 99-102.
44. Sandyk, R., & Brennan, M. J. W. (1982). Impairment of somatosensory feedback control of the tongue in Parkinson's disease: Effect of L-dopa therapy. The South African Journal of Communication Disorders, 29, 49-54.
45. Schulz, G. M., & Grant, M. K. (2000). Effects of speech therapy and pharmacologic and surgical treatments on voice and speech in Parkinson's disease: A review of the literature. Journal of Communication Disorders, 33, 59-88. (Pubitemid 30067615)
46. Swainson, R., Roger, R. D., Sahakian, B. J., Summers, B. A., Polkey, C. E., & Robbins, T. W., (2000). Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: Possible adverse effects of dopaminergic medication. Neuropsychologia, 38, 596-612. (Pubitemid 30109440)
47. Tompkins, C. A., Bloise, C. G. R., Timko, M. L., & Baumgaetner, A. (1994). Working memory and inference revision in brain-damaged and normally aging adults. Journal of Speech and Hearing Research, 37, 896-912. (Pubitemid 24251166)
48. Turner, G. S., & Weismer, G. (1993). Characteristics of speaking rate in the dysarthria associated with amyotrophic lateral sclerosis. Journal of Speech and Hearing Research, 36, 1134-1144. (Pubitemid 23354169)
49. Webster, D. D. (1968). Critical analysis of the disability in Parkinson's disease. Modern Treatment, 5, 87-95.
50. Welter, M. L., Houeto, J. L., Tezanus du Montcel, S., Mesnage, V., Bonnet, A. M., Pillon, B., Arnulf, I., Pidoux, B., Dormont, D., Cornu, P., & Agid, Y. (2002). Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain, 125, 575-583.
51. Wechsler, D. (1997). Wechsler Adult Intelligence Scale III. San Antonio, TX: The Psychological Corporation.
52. Yuan, J., Liberman, M., & Cieri, C. (2006). Towards an integrated understanding of speaking rate in conversation. ICSLP 2006, Available online at: http://ldc.upenn.edu/myl/llog/icslp06-final.pdf, accessed 7 August, 2008.
53. Yorkston, K. M., & Beukelman, D. R. (1981). Assessment of intelligibility of dysarthric speech. Tigard, OR: C. C. Publications.
54. Yorkston, K. M., Beukelman, D. R., Strand, E. A., & Bell, K. R. (1999). Management of motor speech disorders in children and adults (2nd ed.). Austin, TX: Pro-Ed.